{
  "id": "120a4b812ad9a594",
  "title": "Travere Therapeutics Targets April FSGS FILSPARI Decision as IgAN Sales Accelerate , HCU Trial Restarts",
  "description": "20260215T223000Z",
  "content": "",
  "source": "finance.yahoo.com",
  "source_url": "https://finance.yahoo.com/news/travere-therapeutics-targets-april-fsgs-220328679.html",
  "published_at": "20260215T223000Z",
  "fetched_at": "2026-02-16T00:29:41.976443+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://finance.yahoo.com/news/travere-therapeutics-targets-april-fsgs-220328679.html",
    "url_mobile": "",
    "title": "Travere Therapeutics Targets April FSGS FILSPARI Decision as IgAN Sales Accelerate , HCU Trial Restarts",
    "seendate": "20260215T223000Z",
    "socialimage": "https://s.yimg.com/os/en/marketbeat_955/d56f636237eb872ad0b2d7ad2e90b6d2",
    "domain": "finance.yahoo.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}